id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-D-2899-0003,FDA,FDA-2022-D-2899,Request for Extension from Animal Health Institute (AHI),Other,Request for Extension,2022-12-22T05:00:00Z,2022,12,2022-12-22T05:00:00Z,,2022-12-22T19:52:31Z,,0,0,090000648554b7ff
FDA-2022-D-2899-0002,FDA,FDA-2022-D-2899,Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs; Guidance for Industry; Draft Guidance - (GFI) #276,Other,Guidance,2022-11-30T05:00:00Z,2022,11,2022-11-30T05:00:00Z,2023-05-02T03:59:59Z,2024-11-07T00:44:54Z,,1,0,090000648550aaf2
FDA-2022-D-2899-0001,FDA,FDA-2022-D-2899,Effectiveness of Anthelmintics: Specific Recommendations for Products Proposed for the Prevention of Heartworm Disease in Dogs; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2022-11-30T05:00:00Z,2022,11,2022-11-30T05:00:00Z,,2022-11-30T16:17:29Z,2022-26059,0,0,090000648550a1ef